Pharma Stocks
-
Pfizer (NYSE:PFE) scores FDA approval but Wall Street reaction muted
New York, July 12, 2026, 17:19 (EDT) U.S. markets are shut for the weekend, so investors are waiting to see…
Read More » -
BridgeBio Pharma (BBIO) Following Wainua Trial Setback Still Looks Undervalued
BridgeBio Pharma (BBIO) stock recently moved after AstraZeneca reported that its CARDIO-TTRansform trial of Wainua in ATTR-CM did not meet…
Read More » -
Ascendis Pharma (ASND) Stock Looks Above Fair Value As Shares Jump 24%
Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St’s investing ideas for FREE. Ascendis…
Read More » -
Gland Pharma: What Should You Do?
Gland pharma is primarily a generic injectables manufacturing and CDMO (Contract Development and Manufacturing Outsourcing) company. Its growth will be…
Read More » -
How Investors May Respond To Alnylam Pharmaceuticals (ALNY) After Rival ATTR-CM Setback And New Partnerships
Recently, Alnylam Pharmaceuticals gained attention after a rival ATTR-CM therapy from AstraZeneca and Ionis failed in a late-stage trial, while…
Read More » -
FDA’s PADCEV Keytruda Approval for All MIBC Patients Might Change The Case For Investing In Astellas Pharma (TSE:4503)
Pfizer and Astellas Pharma recently announced that the U.S. FDA approved PADCEV (enfortumab vedotin-ejfv) plus Keytruda as both neoadjuvant and…
Read More » -
Should You Buy Eli Lilly Stock? Here’s My Honest Take.
Eli Lilly(NYSE: LLY) is in a league of its own. It’s the largest healthcare company in the world by market…
Read More » -
ACADIA Pharmaceuticals (ACAD) Names A New Chief People Officer, Is It Still Below Fair Value?
Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors…
Read More » -
Is This Biotech Stock a Buy Near Its 52-Week High?
Key Points Vertex Pharmaceuticals is making clinical and regulatory progress with some promising candidates. The company’s most important business is…
Read More » -
Is ACADIA Pharmaceuticals (ACAD) Still Undervalued After The Daybue Win?
Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors…
Read More »
